Business
Economy
Investing
Politics

Top Posts

Stocks have their worst quarter since 2022, raising...

Hershey to resume using chocolate in most products;...

Republican leaders announce two-track plan to end the...

Body found in Colombia amid search for missing...

Trump says his ‘preference’ would be to ‘take...

U.S. crude tops $100 and the S&P 500...

The world economy is experiencing the most severe...

Average U.S. gas price hits $4 for the...

A global jet fuel shortage is raising the...

House Republicans pass DHS funding bill that Democrats...

Business
Economy
Investing
Politics

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024

December 20, 2024

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

next post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

You may also like

Sona Nanotech to Showcase Its THT Cancer Therapy...

November 8, 2024

Skyharbour’s Partner Company Mustang Energy Commences Field Program...

May 27, 2025

Nextech3D.ai: Disrupting the Global Events Management Industry with...

November 5, 2025

VersaBank Signs Deal to Custody Stablecorp’s QCAD Stablecoin

February 4, 2026

Retail Investors Look to Trigger Silver Squeeze 2.0

April 1, 2025

Lantheus increases shareholding in RAD with A$8m placement

January 10, 2025

Top 5 Silver News Stories of 2025

December 30, 2025

Shell Contract Consolidates Top Tier Global Energy Position

September 11, 2025

Further Cu-Au mineralised area identified at Glava Project

January 20, 2026

GTI Energy

December 13, 2024

Fill Out & Get More Relevant News

Your name
Your email

Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

Recent Posts

Stocks have their worst quarter since 2022, raising doubts about Trump’s economic playbook
April 3, 2026
Hershey to resume using chocolate in most products; Reese’s grandson may taste sweet victory
April 3, 2026
Republican leaders announce two-track plan to end the DHS shutdown
April 3, 2026
Body found in Colombia amid search for missing U.S. flight attendant
April 2, 2026
Trump says his ‘preference’ would be to ‘take the oil in Iran’
April 2, 2026

banner ads

Categories

Business (974)
Economy (839)
Investing (4,085)
Politics (747)

Privacy Policy
Terms & Conditions

Disclaimer: smarttradeinsights.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2026 smarttradeinsights.com | All Rights Reserved